SWShanling Wang

Shanling Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shanling Wang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Bing Li

    Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou 450003, PR China

    2 shared publications
  • Haitao Yang

    Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou 450003, PR China

    2 shared publications
  • Hongyan Duan

    Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou 450003, PR China

    2 shared publications
  • Jintao Wu

    Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou 450003, PR China

    2 shared publications
  • Lijie Yan

    Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou 450003, PR China

    2 shared publications
  • Peng Qian

    Department of Cardiology, Henan Provincial People's Hospital, Zhengzhou 450003, PR China

    2 shared publications

Latest Publications

  • Rcan1-1L overexpression induces mitochondrial autophagy and improves cell survival in angiotensin II-exposed cardiomyocytes

    by Hongyan Duan, Yongqiang Li, Lijie Yan, Haitao Yang, Jintao Wu, Peng Qian, Bing Li, Shanling Wang


  • Icariin Inhibits Foam Cell Formation by Down‐Regulating the Expression of CD36 and Up‐Regulating the Expression of SR‐BI

    by Haitao Yang, Lijie Yan, Peng Qian, Hongyan Duan, Jintao Wu, Bing Li, Shanling Wang

    Icariin is an important pharmacologically active flavonol diglycoside that can inhibit inflammation in lipopolysaccharide (LPS)‐stimulated macrophages. However, little is known about the molecular mechanisms underlying the inhibitory effect of Icariin in the formation of foam cells. In this study, macrophages were cultured with LPS and oxidized low‐density lipoprotein (oxLDL) in the presence or absence of Icariin. RT‐PCR and western blot were used to detect the levels of mRNA and protein expression of CD36, scavenger receptor class B type I (SR‐BI) and the phosphorylation of p38MAPK. It was demonstrated that 4 µM or 20 µM Icariin treatment significantly inhibited the cholesterol ester (CE)/total cholesterol (TC) and oxLDL‐mediated foam cell formation (P < 0.05). The binding of oxLDL to LPS‐activated macrophages was also significantly hindered by Icariin (P < 0.05). Furthermore, Icariin down‐regulated the expression of CD36 in LPS‐activated macrophages in a dose‐dependent manner and CD36 over‐expression restored the inhibitory effect of Icariin on foam cell formation. The phosphorylation of p38MAPK was reduced by Icariin, indicating that Icariin reduced the expression of CD36 through the p38MAPK pathway. In addition, Icariin up‐regulated SR‐BI protein expression in a dose‐dependent manner, and SR‐BI gene silencing restored the inhibitory effect of Icariin on foam cell formation. These data demonstrate that Icariin inhibited foam cell formation by down‐regulating the expression of CD36 and up‐regulating the expression of SR‐BI. Therefore, our findings provide a new explanation as to why Icariin could inhibit atherosclerosis. J. Cell. Biochem. 9999:1–9, 2015. © 2014 Wiley Periodicals, Inc. J. Cell. Biochem. 116: 580–588, 2015.